Re: Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR) - The BMJ

Submitted by Anonymous (not verified) on Wed, 10/31/2018 - 07:00

Re: Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)  The BMJThe article by Kessler et al. (1) that concluded that mirtazapine added to SSRIs or SNRIs did not result in improvement merits some additional discussion.